`Start
`End
`Period
`Sort
`
`TOTAL_INTEGRATED_AWP
`1/1/2009
`12/31/2018
`Per=Q
`Sort=A
`
`MOLECULE_TICKER
`RX_01643 Comdty
`RX_01643 Comdty
`RX_01643 Comdty
`
`DRUG_NAME
`ZENAPAX
`ZENAPAX
`ZINBRYTA
`
`MOLECULE_NAME
`DACLIZUMAB
`DACLIZUMAB
`DACLIZUMAB
`
`PRODUCT_INDICATOR
`B
`B
`B
`
`DRUG_STRENGTH
`5MG/ML
`5MG/ML
`150MG/ML
`
`DRUG_PACKAGE_SIZE
`5.000
`5.000
`1.000
`
`DRUG_FORM
`VIALS INJECTABLE
`VIALS INJECTABLE
`SYRINGES DISPOSABLE
`
`Biogen Exhibit 2112
`Mylan v. Biogen
`IPR 2018-01403
`
`Page 1 of 4
`
`
`
`MANUFACTURER_NAME
`REPACKER
`ROCHE
`ABBVIE US LLC
`
`Q1
`
`2009
`Q1_2009
`
`Q2
`
`2009
`Q2_2009
`
`Q3
`
`2009
`Q3_2009
`
`Q4
`
`2009
`Q4_2009
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`2013
`2013
`2012
`2012
`2012
`2012
`2011
`2011
`2011
`2011
`2010
`2010
`2010
`2010
`Q1_2010 Q2_2010 Q3_2010 Q4_2010 Q1_2011 Q2_2011 Q3_2011 Q4_2011 Q1_2012 Q2_2012 Q3_2012 Q4_2012 Q1_2013 Q2_2013
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`7664445.05 8137448.43 10324863.06 8078236.22 647459.66 18931.86 13111.38
`
`8005.80 8715.24
`
`5150.73
`
`1050.39
`
`Page 2 of 4
`
`
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`2016
`2016
`2016
`2015
`2015
`2015
`2015
`2014
`2014
`2014
`2014
`2013
`2013
`Q3_2013 Q4_2013 Q1_2014 Q2_2014 Q3_2014 Q4_2014 Q1_2015 Q2_2015 Q3_2015 Q4_2015 Q1_2016 Q2_2016 Q3_2016
`
`Q3
`
`Q4
`
`Q1
`
`Q2
`
`Q3
`
`Q4
`
`2016
`Q4_2016
`
`Q1
`
`2017
`Q1_2017
`
`Q2
`
`2017
`Q2_2017
`
`Q3
`
`2017
`Q3_2017
`
`Q4
`
`2017
`Q4_2017
`
`Q1
`
`2018
`Q1_2018
`
`Q2
`
`2018
`Q2_2018
`
`1479191.68 9641248.39 18923523.82 24979173.30 24180838.26 23834725.41 20374989.01 115373.13
`
`Page 3 of 4
`
`
`
`Q3
`
`Q4
`
`2018
`2018
`Q3_2018 Q4_2018
`
`Page 4 of 4
`
`